Trials / Completed
CompletedNCT00827255
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but discontinued use after less than 12 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporine Ophthalmic Emulsion 0.05% | One drop two times a day approximately 12 hours apart |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-06-01
- Completion
- 2009-10-01
- First posted
- 2009-01-22
- Last updated
- 2019-04-25
- Results posted
- 2012-07-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00827255. Inclusion in this directory is not an endorsement.